# The evolving landscape: magnetic resonance imaging in active surveillance for prostate cancer management

## TL;DR

This paper discusses how MRI is used to monitor low-risk prostate cancer patients to avoid unnecessary treatment.

## Contribution

It reviews the latest evidence on using MRI in active surveillance for prostate cancer.

## Key findings

- mpMRI is widely used in clinical practice for prostate cancer diagnosis and follow-up.
- There is ongoing debate about inclusion criteria and follow-up requirements for active surveillance.

## Abstract

Since overdiagnosis and overtreatment pose significant risks in managing prostate cancer (PCa), active surveillance (AS) is the most common treatment in low-risk patients. However, there is no general agreement yet on the inclusion criteria and the required follow-up. Multiparametric magnetic resonance imaging (mpMRI) of the prostate was born as a useful device in these patients both in diagnosis and follow-up, and it is widely used in daily clinical practice. We reflect on the most current evidence described in the literature on the topic, its results, and our experience.